EMPLIMET XR 5/25/1000MG TAB

EMPLIMET XR is a combination tablet containing empagliflozin, linagliptin, and metformin in extended-release formulation. This triple-action medication is designed to help manage type 2 diabetes by improving blood sugar control through multiple mechanisms: enhancing insulin secretion, reducing glucose reabsorption in the kidneys, and improving insulin sensitivity. The extended-release formulation allows for once-daily dosing, improving medication adherence. Suitable for patients whose diabetes is not adequately controlled with other antidiabetic agents. Always use as directed by your healthcare provider and maintain regular monitoring of blood glucose levels.